期刊文献+

反义核酸技术应用难点及研究进展 被引量:2

The Clinical Problem and Research Progress of Antisensenucleic Acids Technique
在线阅读 下载PDF
导出
摘要 反义核酸技术已被广泛用于治疗药物、药物靶点确认、探知病理基因的表达。目前对其作用原理的研究集中于其被吸收入细胞的机制、在细胞内的分布、反义核酸序列的最佳长度和性质,并针对体内可能抑制反义核酸活性的影响因素,采取了各种相应的反义核酸优化技术,如对反义核酸的化学修饰、联结高效的转运载体、确定最佳的反义结合位点等,通过这些技术来提高其体内稳定性、跨细胞转运的效率,识别靶序列的特异性,以获得更多更好的反义药物投入实用。 Antisensenucleic acids technique has been widely used in developing new gene-therapy drug, to indentify medicine target, and to study patho-gene expressing. Accordong to some reaserch focus on how the antisensenucleic acids inhibit expression of specific genes that including cellular delivery, intracellular distribution, and select the optimal oligodeoxynucleotide(ODN) size. The development of antisense strategies has generated to overcome the barriers that may affect antisensenucleic acids reaction. These developments including chemical mordification of antisense oligodeoxynu- cleotides, more effective carrier-mediated delivery of oligonucleotides, and selecting accessible sites in the target gene. The use of upgrade ODN can improve stability in vivo, more effective cellular delivery, the specificity of binding target gene so that acauire more and more antisensenucleic acids to throw into utility.
出处 《生物技术通讯》 CAS 2007年第4期655-659,共5页 Letters in Biotechnology
基金 福建省科技厅国际合作重点项目(2004I012)
关键词 反义核酸 反义寡脱氧核苷酸 RNA干扰 核酶 反义结合位点 antisensenucleic acids antisense oligodeoxynucleotide RNA interference ribozyme antisense accessible site
  • 相关文献

参考文献33

  • 1Probst JC.Antisense oligodeoxynucleotide and ribozyme design[J].Methods,2000,22(3):271.
  • 2Benimetskaya L,Loike JD,Khaled Z,et al.Mac-1(CD11b/CD18)is an oligodeoxynucleotide-binding protein[J].Nat Med,1997,3(4):414.
  • 3Vasconcelos MH,Maia LF,Sousa C,et al.Evidence for a specific intracellular localization of an antisense oligonucleotide in k562cells[J].J Pharmacol Sci,2005,99(1):105.
  • 4Roth CM.Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides[J].Biophys J,2005,89(4):2286.
  • 5Stein CA.Two problems in antisense biotechnology:in vitro delivery and the design of antisense experiments[J].Biochim Biophys Acta,1999,1489(1):45.
  • 6Wooldridge JE,Ballas Z,.Krieg AM,et al.Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma[J].Blood,1997,89(8):2994.
  • 7Agrawal S,Zhao Q.Mixed backbone oligonucleotides:improvement in oligonucleotide-induced toxicity in vivo[J].Antisense Nucleic Acid Drug Dev,1998,8(2):135.
  • 8Zhang R,Lu Z,Zhao H,et al.In vivo stability,disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in rats[J].Biochem Pharmacol,1995,50(4):545.
  • 9Kalota A,Karabon L,Swider CR,et al.2'-deoxy-2'-fluoro-betaD-arabinonucleic acid(2'FANA) modified oligonucleotides(ON) effect highly efficient,and persistent,gene silencing[J].Nucleic Acids Res,2006,34(2):451.
  • 10Falkiewicz B.Peptide nucleic acids and their structural modifications[J].Acta Biochim Pol,1999,46(3):509.

同被引文献18

  • 1黄卫平.免疫学分析法在检测滥用药物中的应用[J].中国药物滥用防治杂志,2005,11(3):164-168. 被引量:5
  • 2Wang JL,Wang PC. The effect of aging on tile DNA dam- age and repair capacity in 2BS cells undergoing oxidative stress[J]. Mol Biol Rep,2012.39( 1 ) :233-241.
  • 3Lu X,Tan CK,Zhou JQ,et al. Direct inleraclion of prolif- erating cell nuclear antigen with lhe small subunit of DNA polymerase deha[J]. J Biol Chem,2002,277(27) :24340- 24345.
  • 4Goldsby RE, Lawrence NA. Hays I.E, et al. Defective DNA polymerase-delta proofreading causes Cancer susceptibili- ty in miee[J]. Nat Med,2001,7(6) :638-639.
  • 5Goldsby RE, Hays I.E, Chen X, et al. High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading[J]. Proc Natl Aead Sci U S A, 2002, 99(24) :15560-15565.
  • 6Venkatesan RN, Treuting PM, Fuller ED, et al. Mutation at the polymerase active site of mouse DNA polymerase delT.a increases genomic instabilily and accelerates tumori- genesis[J]. Mol Cell Biol. 2007,27 ( 21 ) : 7669-7682.
  • 7Li H,Xie B, Rahmeh A,el al. Direct interaction of p21 with p50,the small subunit of human DNA polymerase deha [J]. Cell Cycle,2006,5(4) :428-436.
  • 8Fazlieva R, Spittle CS, Morrissey D. et al. Proofreading exonuclease activity of human DNA polymerase delta and its effects on lesion-bypass DNA synthesis[J]. Nucleic Acids Res, 2009,37 (9) : 2854-2866.
  • 9Michael WS, Yoshihiro M, Lawrence AL. High fidelity and lesion bypass capability of human DNA polymerase [J]. Biochimie,2009,91(9) :1163-1172.
  • 10Narita T, Tsurimoto T, Yamamoto J, et al. Human repli- cative DNA polymerase 3 can bypass T-T(6-4) ultraviolet photoproducts on template strands[J]. Genes Cells, 2010, 15(12) : 1228-1239.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部